Ceftriaxone and Cefazolin Spectrum Coverage

Comparative Antimicrobial Spectrum

• The Surgical Infection Society and Infectious Diseases Society of America guidelines list ceftriaxone (with metronidazole) as a recommended combination therapy for intra-abdominal infections, while cefazolin is listed as a narrower-spectrum option 1
• For mild to moderate intra-abdominal infections, cefazolin plus metronidazole is considered a reasonable option with narrower spectrum than ceftriaxone 2

Clinical Applications Reflecting Spectrum Differences

• Ceftriaxone is preferred for intra-abdominal infections (as a second-choice option with metronidazole) 1
• Ceftriaxone is preferred for severe community-acquired infections 2

Evidence-Based Comparison

• The Infectious Diseases Society of America recommends cefazolin over ceftriaxone specifically for MSSA infections 3

Clinical Implications

• The broader spectrum of ceftriaxone comes with increased risk of promoting antimicrobial resistance and potential for collateral damage to normal flora 1
• Cefazolin should be preferred when narrower spectrum is adequate, particularly for MSSA infections 3

Common Pitfalls and Caveats

• Using ceftriaxone when narrower-spectrum agents would be sufficient may contribute to antimicrobial resistance 1
• For MSSA infections, cefazolin is generally preferred over ceftriaxone despite ceftriaxone's broader overall spectrum 3